The independent source for health policy research, polling, and news.
13,241-13,260 of 113,136 results
"The unvaccinated are ... risking the lives of others who may die of preventable diseases who can't get their needed health care," said Dr. Marschall Runge, dean of the University of Michigan Medical School. As if to prove his point, new research finds that 703 deaths at nursing homes over a 10-week period this summer would've been prevented had more workers been vaccinated.
The Food and Drug Administration determined that additional study by an advisory committee would not be required in reviewing a third Pfizer covid shot for those aged 16 and 17. News outlets report on other developments related to youth vaccines.
The Boston Globe says the National Guard is being called in to help at hospitals and long-term care facilities facing high volumes of covid cases. In Maine, care may have to be rationed for the first time, and Wisconsin's top health official calls for federal help in the face of staffing shortages.
Researchers have found that the coronavirus infects both fat cells and certain immune cells within body fat, prompting a damaging defensive response in the body, The New York Times writes. The findings could lead to new covid treatments that target body fat.
In better news, the U.S. reached a milestone Wednesday: 200 million Americans are now fully vaxxed.
The two-dose antibody drugs are the first intended for long-term prevention against covid infection, rather than a short-term treatment for people with compromised immune systems.
In an interview with the AP, Dr. Rochelle Walensky provided details on the more than 40 known omicron cases in the U.S. Most were in vaccinated patients who only showed mild symptoms like cough, congestion and fatigue. Only one person has been hospitalized.
"When we see real-world data, will determine if the omicron is well covered by the third dose and for how long. And the second point, I think we will need a fourth dose,” Pfizer CEO Albert Bourla told CNBC. Pfizer is researching the efficacy of its booster and original vaccine course against the omicron covid variant.
Today's early morning highlights from the major news organizations.
Editorial pages delve into these public health topics.
Opinion writers examine these covid related issues.
Read recent commentaries about drug-cost issues.
Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.
A new study found hospitals that were covered by the expansion of Medicaid haven't seen an improvement in quality scores or better staffing levels. Water quality issues, HIV/AIDS matters, toxic gas, legal marijuana and more are also in the news.
The Federal Trade Commission's investigation centered on alleged 4,000% boosts in the price of toxoplasmosis treatment Daraprim. Meanwhile, news outlets cover the testimony from ex-Theranos CEO Elizabeth Holmes over the failure of the blood-testing company.
A report in Bloomberg detailing the plan calls the U.S. maternal mortality rate "alarmingly high." The strategy calls for extending postpartum coverage under Medicaid to 12 months. Meanwhile, USA Today details where to find the best hospitals in which to have a baby.
The Facebook founder and his wife are adding the money to their charitable foundation over 15 years. In other health industry news, United Healthcare loses a $60 million lawsuit, and Centene settles with the state of Kansas with a $28 million payment.
Surgeon General Vivek Murthy says there was a mental health crisis among younger Americans even before the pandemic struck, with one in three high school students reporting persistent sadness or hopelessness. News outlets cover other mental health issues.
A study of health insurance data for more than 7.2 million people showed a nearly 70% lower risk of developing Alzheimer's in the next six years among those who took sildenafil (originally designed as a heart drug) versus those who didn't. News outlets note, however, that correlation isn't causation.
A plan to shift the political leanings of the Supreme Court did not get support from a bipartisan presidential panel on judicial reform.
© 2026 KFF